OmniCorder Technologies, Inc. (OTCBB:OMCT) today announced that the Company’s BioScanIR(R) System was the subject of a recent study published in the June issue of Physics in Medicine and Biology. A team led by Dr. Tiziano Binzoni, and Pr. Daniel Rufenacht, Departments of Radiology and Physiology, Faculty of Medicine, University of Geneva, Switzerland, examined the use of the company’s Quantum Well Infrared Photodetector (QWIP) technology, used in the Company’s BioScanIR(R) System, to map human skeletal muscle perforator vessels.
